Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma
Recruiting
N/A
Interventional Study
Chronic Obstructive Pulmonary Disease (COPD)
Bronchial Asthma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 1,000 (estimated)
- Sponsor
- Charles University, Czech Republic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Comprehensive assessment and interventions to promote adherence to inhaled therapy in patients with bronchial asthma and chronic obstructive pulmonary disease involving health care professionals caring for these patients in different settings and using the Five Steps Assessment tool and artificial intelligence methods and tools.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
PATIENTS
Inclusion Criteria:
1. signed informed consent,
2. age ≥ 18 years,
3. previously diagnosed BA/COPD meeting GOLD 2024 and GINA 2024 diagnostic criteria,
4. ability to cooperate,
5. at least 8 weeks without exacerbation,
6. use of a particular inhaler for at least 3 months.
Exclusion Crite…
Contacts